Patents by Inventor Paul Fredrick Widboom

Paul Fredrick Widboom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20220372163
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: May 30, 2022
    Publication date: November 24, 2022
    Applicant: TRISHULA THERAPEUTICS, INC.
    Inventors: Vanessa SOROS, Maria KOVALENKO, John CORBIN, Courtney BEERS, Paul Fredrick WIDBOOM, Joseph Robert WARFIELD
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20220340680
    Abstract: Provided herein are antibodies with binding specificity for CD39 and compositions comprising the antibodies, including pharmaceutical compositions, diagnostic compositions and kits. Also provided are methods of using anti-CD39 antibodies for therapeutic and diagnostic purposes.
    Type: Application
    Filed: April 20, 2022
    Publication date: October 27, 2022
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF
    Publication number: 20220267441
    Abstract: Disclosed are anti-CD45 antibodies, antigen binding fragments thereof, and antibody drug conjugates (ADCs) that specifically bind to human CD45. Such antibodies and ADCs are useful in therapeutic methods, including methods of depleting CD45+ cells from a patient. The compositions and methods described herein can be used to treat a disorder directly, for instance, by depleting a population of CD45+ cancer cells or autoimmune cells. The compositions and methods described herein can also be used to prepare a patient for hematopoietic stem cell transplant therapy, and to improve the engraftment of hematopoietic stem cell transplants, by selectively depleting endogenous CD45+ cells prior to the transplant procedure.
    Type: Application
    Filed: October 22, 2021
    Publication date: August 25, 2022
    Inventors: Anthony Boitano, Michael Cooke, Charlotte Fenton McDonagh, Rahul Palchaudhuri, Rajiv Panwar, Bradley Pearse, Paul Fredrick Widboom, Patricia Ann Cruite
  • Anti-CD39 antibodies
    Patent number: 11345757
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: May 31, 2022
    Assignee: Trishula Therapeutics, Inc.
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES
    Publication number: 20220135689
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: November 18, 2021
    Publication date: May 5, 2022
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20210403593
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: September 7, 2021
    Publication date: December 30, 2021
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • Anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies and methods of using anti-HLA-G antibodies
    Patent number: 11208487
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: December 28, 2021
    Assignee: Tizona Therapeutics
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES
    Publication number: 20210340259
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: September 26, 2019
    Publication date: November 4, 2021
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20210009708
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: July 30, 2018
    Publication date: January 14, 2021
    Inventors: Vanessa SOROS, Maria KOVALENKO, John CORBIN, Courtney BEERS, Paul Fredrick WIDBOOM, Joseph Robert WARFIELD
  • ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES
    Publication number: 20200102390
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: September 26, 2019
    Publication date: April 2, 2020
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20190062448
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: July 30, 2018
    Publication date: February 28, 2019
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield